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Summary: In order to determine optimal conditions for the clinical application of leukocyte acid sialidase
determination, we have studied some characteristics of the enzyme giving attention more specifically to the
enzyme's thermolability and the influence of potential effectors.
The enzyme has a pH Optimum around 4 and a Km value of 0.25 mmol · 1.
A decrease of activity is observed when the enzyme is measured in leukocytes isolated from total blood or
leukocytes containing plasma kept for several hours at room temperature. On the other hand, in a leukocyte
homogenate, the enzyme is stable at 0 °C for 8 hours althoügh pronounced thermolability is observed at 23
and 37 °C and total inactivation occürs after 10 minutes at 50 °C. The addition of albumin to the homogenate
partially protects the enzyme. Residual activities of 40% and 50% were measured in leukocytes and leukocyte
homogenates frozen during 2 months at — 20 °C.
A marked Inhibition was obtained by Triton X-100, sodium taurocholate, and methoxyphenyl-N-acetylneur-
aminic acid.
Immediate Isolation of the leukocytes after the blood drawing and subsequent homogenization at 0 °C of a
dense pellet make it possible to achieve enzyme linearity and reproducible results.
Bestimmung der Methylumbelliferyl-N-acetylneuraminsäure spaltenden sauren Sialidase für klinische Zwecke
Zusammenfassung: Zur Festlegung optimaler Bedingungen für die klinische Anwendung der Bestimmung
von saurer Sialidase der Leukocyten haben wir einige Eigenschaften des Enzyms untersucht und dabei be-
sonders auf die Thermolabilität und den Einfluß möglicher Effektoren geachtet.
Das Enzym hat sein pH-Optimum bei pH 4 und eine M/c/we/w-Konstante von 0,25 mmol · 1.
Wir beobachteten einen Aktivitätsverlust, wenn das Enzym in Leukocyten gemessen wurde, die aus Vollblut
isoliert worden waren oder in Plasma für mehrere Stunden bei Raumtemperatur gehalten wurden. Dagegen
ist das Enzym in einem Leukocytenhomogenat für 8 Stunden bei 0 °C stabil, während eine ausgeprägte Ther-
molabilität bei 23 und 37 °C sowie völlige Inaktivierung nach 10 Minuten bei 50 °C beobachtet wird. Zugabe
von Albumin zum Homogenat schützt das Enzym teilweise. Restaktivitäten von 40% und 50% wurden in
Leukocyten bzw. Leukocytenhomogenat geinessen, die während 2 Monaten bei —20 °C aufbewahrt wurden.
Eine deutliche. Hemmung wurde mit Triton X-100, Natrium-Taurocholat und Methoxyphenyl-N-acetylneu-
raminsäure erhalten.
Unmittelbare Isolierung der Leukocyten nach der Blutentnahme und nachfolgende Homogenisierung bei
hoher Zelldichte und 0 °C lassen Linearität und reproduzierbare Ergebnisse erreichen.
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Introduction
Methylumbelliferyl-N-acetyl-a-O-neuraminic acid,
a fluorimetric Substrate for sialidase (EC 3.2.1.18)
was synthesized by Polier et al. (1), Werner &
O'Brien (2), and Eschenfelder (3).
Since the enzyme cannot be measured in plasma (re-
sults not shown), we have studied the leukocyte en-
zyme characteristics in order to find optimal condi-
tions for the determination. The assay of this enzyme
is useful for fast biochemical investigation of sus-
pected cases of sialidosis, a disease characterized by
a sialidase deficiency.
The effect on sialidase of the time lapse between
blood sampling and Isolation of the leukocytes was
examined and attention was focused on enzyme sta-
bility at different temperatures between —20 °C and
+50 °C and the influence of albumin and detergents.
Since the fluorescent end product of the reaction is
measured by simple alkalization, this method has
permitted the investigation of possible Inhibition by
other substances containing terminal sialic acid (and
therefore used in colorimetric sialidase determina-
tions), without colour development interference.
Materials and Methods
Chemicals
Methylumbelliferyl-N-acetyl-a-D-neuraminic acid was prepared
by Mrs. U. Rose, Heidelberg. Sodium acetate, sodium carbonate,
sodium hydrogencarbonate, potassium phosphate and Triton Χ-
Ι 00 were obtained from Merck, Darmstadt, W. Germany. Sialyl-
lactose, fetuin III and IV, mucin, colominic acid, albumin and so-
dium taurocholate were purchased from Sigma, St. Louis, MO,
USA. Methoxyphenyl-N-acetylneuraminic acid was a gift from
the National Institute of Allergy and Infectious Diseases, NIH,
Bethesda, MD, USA.
Isolat ion of leukocytes and homogenate prepara t ion
Leukocytes were isolated from 20 ml of heparinized blood by Sed-
imentation (generally between l and 3 hours) at room tempera-
ture followed by two washings with isotonic saline. In general,
contamination by ced blood cells was minimal and lysis of the re-
maining red blood cells was obtained by adding 0.3 ml of distilled
water for 20 seconds and restoring the normotonicity immediately
by adding a 30 times greater volume of isotonic saline. Cold bU
distilled water (0.5 ml) was added to the pellet and homogeniza-
tion of the cells was achieved during exactly 30 seconds in a Pot-
ter-Elvejehm vessel kept in ice. In this procedure, no estimation of
cellular destruction or cell count was performed, because activity
was expressed per mg protein. The extract was used immediately
for measuring the enzyme catalytic activity unless otherwise stat-
ed.
In other experiments, we tested the effect of mechanical forces by
homogenizing a pellet during different times from short periods
up to 5 minutes, taking repeat samples for catalytic activity mea-
surement. Pipettable homogenates could be obtained after a 5 se^
cond homogenization period and the enzyme activity in this hom-
ogenate was therefore used s the 100% reference. The homo-
genization was then continued while taking repeat homogenate
samples. With increasing times of homogenization pipetting bc-
came easier. An arbitrary period of 30 seconds was therefore es-
tablished s the Standard method of homogenate preparation.
Enzyme determinat ion
Protein was determined according to Lowrytt al. (4). Acid siall·
dase was measured s follows: In small glas tiioes (internal diame-
ter 0.3 cm, length 3 cm) 10 μΐ of leukocyte homogenate togethef
with 2 μΐ of l mol · l"1 sodium acetate buffer pH 4 and 10 μΐ of 0.2
mmol · Γ1 Substrate (total volume 22 μΐ) were incubated at 37 °C
for 15 and 30 min. Substrate blanks with buffer were incubated
separately. The reaction was stopped with 0.250 ml of 0.5 mol · Γ1
sodium carbonate-hydrogen carbonate pH 10.7 and homogenate
was added to the blanks, The fluorescence was read in the high
sensitivity sample holder of the Turner fluorimeter using excita-
tion and emission wavelengths of 360 and 460 nm respectively.
The pH activity curve was deteffnined by the routine test, using l
mol · Γ1 sodium acetate pH 3—6, and l mol · l"1 potassium phos-
phate pH 6.5 and 7.
For the thermolability studies, either total blood or plasma con-
taining the leukocytes was kept at room temperature, and siali-
dase was determined at different times up to 8 hqurs after the
blood drawing, without and with albumin (final concentration 5
g/l). In a second set of experiments, leukocyte homogenates were
kept at different temperatures (0, 23, 37, 50 °C) for up to 8 hours
and the enzyme activity measured at regul r time intervals. In
another series of experiments, either leukocyte pellets or homo-
genates were kept frozen at —20°C, Therefore either intact
leukocytes were frozen under a small amount of physiological sa-
line or the leukocyte homogenate was transferred to small stop-
pered glass tubes immediately after homogenization and stored at
—20 °C. The homogenate was unfrozen only once at the time of
the enzyme determination which was carried out in the same tube.
For the Inhibition studies, graded amounts of potential Inhibitors
(maximal final test concentration in parentheses) such s sialyllac-
tose (0.5 g/l), fetuin III and IV, mucin, colominic acid (each 1.15
g/l), Triton X-100 (2 g/l), Na-taurocholate (10 g/l) and methoxy-
pheHyl^N-acetylneuraminic acid (6 g/l) were added to the incuba-
tion medium.
Results
The pH activity curve shows an Optimum at 4 (fig.
1). The protein concentration of the homogenates
varied between 3 and 17.6 g/l. For the thermolability
studies, the protein concentration was 10 g/l.
Residual activity of sialidase was unchanged after an
homogenization period up to 30 seconds. After l, 2,
3 and 5 minutes, the activity dropped to 91, 73, 60
and 0% respectively.
The use of a dense leukocyte homogenate allows
short incubation times of 15 and 30 minutes so that
strict reaction line rity and minimal non-enzymatic
Substrate hydrolysis was obtained.
Using 10 samples, normal catalytic activities be-
tween 1.10 and 6.50 nmol of Substrate hydrolysed
per hour and per mg protein (mean value of 2.23)
were obtained with a coefficient ot Variation within
10%.
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Fig. l. pH activity curve of a leukocyte ho m ge na te. The Stan-
dard method was used with l mol · i"1 sodium acetate
buffer pH 3—6 and l mol · l""1 potassium phosphate buffer
pH 6.5 and 7.
Using Substrate concentrations between 0.012 and
2.4 mmol · Γ1, a Km value of 0.25 mmol · Γ1 was
found. It should be remarked however that a much
lower Km value in the order of 0.052 mmol -1"1 can
be obtained when other Substrate concentrations
(between 0.003 and 0.12 mmol · l"1) are used (5)1)·
Either total blood or leukocyte containing plasma
was kept at 23 °C and the catalytic activity of sialida-
se determined at fixed intervals of l, 2, 4 and 8
hours. No difference was observed between plasma
or total blood, and a time-dependent loss of activity
of the supposedly intact intralysosomal sialidase was
observed. After 2 and 8 hours, a residual catalytic
activity of 72 and 50% respectively remained (total
number of 8 samples assayed).
In a second series of experiments on the influence of
temperature, we noted that after 8 hours at 0°C,
there is a recuperation of 90% of the enzyme in
leukocyte homogenates, but the residual catalytic ac-
tivity dropped to about 50% after the same period at
23 °C and the total enzyme aetivity was lost after 4
hours at 37 °C arid 10 min at 50 °C. When we added
albumin (final concentration pf 5 g/l) to the homo-
genate there was marked enzyme prptection with re-
tardation of inactivation at 23 and 37 °C (fig. 2).
After an 8 weeks storage period of pellets at —20 °C,
the residual activity was approximately 40%. On the
pther band, when determinations were carried out
on homogenates kept under the same conditions, the
mean value was 50%.
All substances tested indeed inhibit the enzyme to
variable degrees, with a high Inhibition by methoxy-
phenyl-N-acetylneuraminic acid, another sialidase
Substrate (fig. 3).
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Fig. 2. Sialidase activity in the homogenate kept at different
temperatures without and with albumin at a final concen-
tration of 5 g/l.
O—O 0°C, with albumin
O—O 0 °C, without albumin
χ—χ 0 °C, 6 times frozen, without albumin
A—Δ 23 °C, with albumin
Δ—Δ 23 °C, without albumin
37 °C, with albumin
37 °C, without albumin
0.25 0.50 1.00
Fraction of maximal Inhibitor concentration used
Fig. 3. Possible effectors were added to the incubation medium in
different amounts and the catalytic activity of sialidase was
measured at the respective effector concentrations.
Symbol Inhibitor
A—A Sialyllactose
O—O Fetuin IV
O—O Fetuin III
D—D Mucin
D—D Colominic acid
χ—χ Triton X-l 00
Δ—Δ Na-Taurocholate
+—+ Methoxyphenyl-NANA
Maximal
concentration
used
500 mg/1
1.15 g/l
1.15 g/l
1.15 g/l
1.15 g/l
2 g/l
10 g/l
6 g/l
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Discussion
The fluorimetric sialidase determination with this
Substrate was first introduced by Potier (l, 6, 7) and
in a previous paper we described the measurement
of acid sialidase in cultured fibroblasts (8).
For the study of leukocyte sialidase, most authors
have used leukocyte extracts made either by sonica-
tion or homogenization (l, 6—10). Since mechanical
homogenization is an acceptable method for making
leukocyte extracts with expression of the results per
mg protein, we did not perform cell counts. For the
isolation of the leukocytes, we have found that the
catalytic activity of sialidase (per mg protein) is ap-
proximately 50% when dextran Sedimentation of the
leukocytes is used instead of simple Sedimentation,
but we have not further examined the reasons for
this discrepancy. This observation however Stresses
the importance of using a standardized isolation
procedure.
The use of intact leukocytes instead of homogenates
has been advocated by Kuriyama et al. (11) because
loss of activity can occur during homogenization. It is
not understood at the present time whether Substrate
can either penetrate the lysosomes or if there is par-
tial rupture of the lysosomal and cellular membrane
in the incubation mixture with subsequent release of
enzymes into the medium. In our hands, no dimin-
ished activity was observed when the pellet was
homogenized during short periods at 0°C. Intact
leukocytes äs well äs homogenates lend themselves
to sialidase determination äs long äs a strictly stan-
dardized procedure is followed for isolation and
homogenization.
The pH 4 Optimum of the enzyme corresponds to
that of a sedimentable leukocyte sialidase, which is
also optimally active at this pH with sialyllactose äs
the Substrate (12). Published pH optima using the
same fluorescent Substrate (l, 9) are very similar, al-
though somewhat less acidic (between pH 4.2 and
4.5). This acid pH Optimum makes it reasonable to
assume that the enzyme normally functions within
lysosomes although this hypothesis has not been
strictly proven.
The Km value of 0.25 mmol · 1 is in very close
agreement with the results of Potier (1) and Marche-
sani (9). Using labeled sialyloligosaccharides, siali-
dase has also been determined in leukocytes by Ku-
riyama et al. (11) and Strecker et al. (13) and Km
values between 1.5 and 4.5 mmol- 1 were ob-
tained1). Owing to Substrate scarcity, the initial sub-
]) Dependence of the Km value on Substrate concentration is due
to the fact that higher concentrations of methylumbelliferyl-N-
acetyl-a-D-neuraminic acid inhibit the enzyme äs we have
found with other sialidases.
strate concentration used was about 0.1 mmol -1"1.
Since methylumbellifefyl-N-acetyl-a-D-neuraminic
acid is now commercially available (Koch Light, Suf-
folk, England), we recommend final concentrations
of 0.5 mmol · 1 (about twice the Km value), thus
avoiding Substrate Inhibition, high blank values and
the high cost of Substrate.
The observation of the gradual loss of enzyme activi-
ty when a blood sample was kept at room tempera-
ture makes it imperative to isolate leukocytes äs
soon äs possible, preferably immediately after blood
drawing.
On the other band, the enzyme stability at 0 °C con-
trasts with the fibroblast sialidase which looses most
of its activity during the same period of time (8).
Thus, it can be conclüded that determinations done
on leukocyte homogenates which have been kept in
ice for some time are reliable. However, we have
further observed that sialidase is inactivated when
homogenates are kept at room temperature or 37 °C,
while a few minutes at 50 °C suffices to completely
inactivate the enzyme. this inactivation can be par-
tially prevented by adding albumin, äs noted pre-
viously for fibroblast sialidase (8). In the routirie test
no addition is necessary, because the short incuba-
tion time allows the reaction to proceed linearly. On
the basis of therinolability and other parameters,
such äs pH Optimum and the effect of octyl-ß^gluco^
side, two sialidase fractions have been described in
human leukoeytes (7).
Sialidase in intact leukocytes
 :pr -homogenates is
equally inactivated when kept at -20 °C, although
we have obtained some higher values for residual ac-
tivity than previöusly reported (9), probably because
we have thawed each homogenate only once at the
time of enzyme determination. According to Suzuki
et al. (10), normal leukocytes contain a freeze-labile
and freeze-stable component. The latter amounts to
approximately 25—35% of the total catalytic activity
and would represent the remaining activity in adult
patients with ß-galactosidase^sialidase deficiency.
We have reported previously on the deficiency of
leukocyte acid sialidase in a patient with the chefry
red spot myoclonus syndrome (8).
From figure 3, it is clear that all substances tested
indeed inhibit the enzyme to variable degrees. The
Inhibition by sialyllactose and by fetuin, in concen-
trations comparable to those used for £olorimetric
oligösaccharide or glycoprotein sialidase assays with
the same substances, is only minimal. In contrast,
methioxyphenyl-N-acetylneuraminic acid (another
sialidase Substrate) is a potent Inhibitor and has a
remarkable effect even at low cotfcentrations. 1t is
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not unexpected that bovine submaxillary mucin and
colomjnic acid are also inhibitory because they con-
tain N-acetylneuraminic acid, which is terminally
linked 2' —> 6' in the first compound and 2' —> 8'
in the latter homopolymer. The last Substrate has al-
so been used recently to investigate some character-
istics of the enzyme (14). Except for methoxyphen-
yi-N-acetylneuraminic acid, Triton X-100 and sodi-
um taurocholate have the highest inhibitory effect
Using the same Substrate, a comparable Inhibition by
Triton X-100 was reported (9); other effectors, such
äs CaCt and N-acetylneuraminic acid, have also
been studied (1). With sialyllactose äs Substrate, the
inhibitory effect of Triton X-100, deoxycholate and
a series of Chloride salts, has also been reported (12).
Conclusion
The clinical detennination of leukocyte sialidase is
feasible if some precautions are taken. It is impor-
tant that the leukocytes are isolated without delay
after the blood drawing. Either fresh leukocytes in
toto or dense extracts can be used. In the latter case,
the homogenization time should be short, the homo-
genate dense and the procedure itself and subse-
quent handling of the homogenate done at 0 °C and
incubation times should not exceed 30 minutes. No
albumin addition is necessary, since Substrate pro-
tection allows reaction linearity.
Note added to proof
According to Verheyen et al. (Abstracts of the Mee-
ting of the European Study Group on Lysosomal Di-
seases, 1983), isolated lymphocytes should be used
for the diagnosis of sialidosis and galactosialidosis.
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